Literature DB >> 33750525

Silent Hypoxemia of COVID-19 Pneumonia: Typical Courses With Implications for Outpatient Care.

Christian Miller, Robert Stangl, Christoph Adler, Marco Strohm, Carina Bernardo, Alex Lechleuthner, Anja Viethen.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33750525      PMCID： PMC8119661          DOI： 10.3238/arztebl.m2021.0115

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

1.  Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance.

Authors:  Matiram Pun; Sara E Hartmann; Michael Furian; Adrienna M Dyck; Lara Muralt; Mona Lichtblau; Patrick R Bader; Jean M Rawling; Silvia Ulrich; Konrad E Bloch; Marc J Poulin
Journal:  Front Physiol       Date:  2018-06-04       Impact factor: 4.566

Review 2.  Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?

Authors:  Jorge Soliz; Edith M Schneider-Gasser; Christian Arias-Reyes; Fernanda Aliaga-Raduan; Liliana Poma-Machicao; Gustavo Zubieta-Calleja; Werner I Furuya; Pedro Trevizan-Baú; Rishi R Dhingra; Mathias Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2020-06-06       Impact factor: 1.931

Review 3.  Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19.

Authors:  Luigi Vetrugno; Tiziana Bove; Daniele Orso; Federico Barbariol; Flavio Bassi; Enrico Boero; Giovanni Ferrari; Robert Kong
Journal:  Echocardiography       Date:  2020-04-15       Impact factor: 1.724

Review 4.  The pathophysiology of 'happy' hypoxemia in COVID-19.

Authors:  Sebastiaan Dhont; Eric Derom; Eva Van Braeckel; Pieter Depuydt; Bart N Lambrecht
Journal:  Respir Res       Date:  2020-07-28

5.  Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.

Authors:  Martin J Tobin; Franco Laghi; Amal Jubran
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.